DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: The analysis of both types of mutations, the study of their positions along the DMD gene and their effects on the transcript processing and protein levels helps to define the correlations with clinical presentation and to build a clear understanding of the molecular pathology of dystrophinopathies.